The human astrocytoma cell line CCF-STTG1 accumulates [ 3 H]2-AG through an Na -and energy-independent process, with a K m of 0.7 AE 0.1 ìM. Non-radioactive 2-AG, anandamide or the anandamide transport inhibitor 4-hydroxyphenyl arachidonamide inhibit [ 3 H]2-AG uptake with half-maximal inhibitory concentrations (IC 50 ) of 5. 
INTRODUCTION
Two endogenous cannabinoid compounds, anandamide (arachidonylethanolamide) and 2-arachidonylglycerol (2-AG), have been identi®ed in the brain [1±6] . Both compounds activate cannabinoid receptors producing a spectrum of cannabimimetic effects, which include movement inhibition, pain relief and vasodilation [7] .
Anandamide is released from neurons in an activitydependent manner [2, 6] and is inactivated by transport into cells followed by intracellular hydrolysis. Anandamide transport is mediated by a high-af®nity, Na -independent carrier and is selectively inhibited by 4-hydroxyphenyl arachidonamide (AM404) [8, 9] . Hydrolysis of anandamide to arachidonic acid and ethanolamine is catalyzed by a membrane-bound amidohydrolase enzyme [10±12], which has been puri®ed and molecularly cloned [13, 14] . 2-AG may be produced by cleavage of 1,2-diacylglycerol generated by phospholipase C (PLC) acting on phosphatidylinositol bisphosphate [15] . The mechanisms mediating 2-AG inactivation are still only partially understood, but the ability of 2-AG to inhibit [ 3 H]anandamide transport in human astrocytoma cells [16] and to serve as a substrate for anandamide amidohydrolase [17, 18] suggest that 2-AG and anandamide may share a common inactivation route.
As a test of this hypothesis, here we have investigated the biological disposition of [ 3 H]2-AG in human astrocytoma cells. Our results suggest that 2-AG and anandamide may be internalized in these cells via a common carriermediated process. By contrast, the intracellular hydrolysis of 2-AG to arachidonic acid and glycerol may be catalyzed by an enzyme activity distinct from anandamide amidohydrolase.
MATERIALS AND METHODS
Chemicals: Anandamide and palmitylethanolamide were prepared as described [1] ; 2-AG was from Deva Biotech (Hartboro, PA); arachidonic acid from Nu Check-Prep (Elysian, MN); AM404 from Tocris (Ballwin, MO); triacsin C from Biomol (Plymouth Meeting, PA); prostaglandin E 2 and (E)-6-(bromomethylene) tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one from Cayman (Ann Arbor, MI); sulphobromophthalein, digoxin, taurocholic acid, quinidine, verapamil and phloretin from Sigma (St. Louis, MO). All organic solvents were from Burdick and Jackson.
Transport assay: Human astrocytoma CCF-STTG1 cells (American Type Culture Collection, Rockville, MD) were grown in 24-well plates with RPMI 1640 medium containing FBS (10%) and glutamine (1 mM) [16] . Con¯uent cultures were rinsed with Tris±Krebs' buffer at 378C, incubated for 4 min with buffer containing [ 3 H]2-AG (for kinetic analyses: 28±1600 nM; for inhibition assays: 30 nM; 100 mCi/mmol; New England Nuclear, custom synthesized) either at 378C or 0±48C, rinsed with buffer containing bovine serum albumin (BSA, 0.1%), and disrupted by sonication in buffer containing Triton X-100 (1%). Radioactivity in samples was measured by liquid scintillation counting. In some experiments, anandamide transport was measured using [ 3 H]anandamide (30 nM, 220 Ci/mmol, New England Nuclear). For inhibition assays, the cells were preincubated for 10 min with test compounds at appropriate concentrations. The same concentrations of test compounds were also added to the ®nal incubations, which were carried out for an additional 4 min period. Concentrations required for half-maximal inhibition of transport (IC 50 ) were determined by non-linear least square ®tting of the data, using the software GraphPad Prism (GraphPad Software, San Diego, CA).
Hydrolysis assay: Following incubations with [
3 H]2-AG or [ 3 H]anandamide, the cells were rinsed and disrupted by sonication in methanol at 0±48C for 30 s. Lipids were extracted with chloroform (chloroform/methanol/buffer, 2:1:1; vol./vol./vol.). The lipid extracts were analyzed by thin-layer chromatography (TLC) on silica gel G plates (Analtech). TLC analyses were carried out using either ethylacetate/methanol/water/ammonium hydroxide (20: 1:10:1) or chloroform/methanol/ammonium hydroxide (80:20:1) as solvent system. The lipids were visualized with a 10% solution of phosphomolybdic acid (Sigma, Saint Louis, MO) in ethanol followed by heating at 2508C. Bands with the mobility of authentic standards were scraped off the TLC plates for radioactivity determination.
Statistical analyses: Statistically signi®cant differences were determined by ANOVA, followed by Bonferroni's multiple comparison test. 3 H]2-AG hydrolysis. Conversely, the anandamide amidohydrolase inhibitor, (E)-6-(bromomethylene) tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one (BTNP; 5 ìM) [19] has no effect on [ 3 H]2-AG accumulation (Fig. 1b) or metabolism (Fig. 2) .
RESULTS
If Fig. 2 ). However, this increase is not suf®cient to compensate for the substantial loss of radioactivity in the phospholipid fraction and we did not investigate further its molecular basis. These ®ndings suggest that arachidonic acid inhibits 
